Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.290
+0.010 (0.78%)
At close: Apr 23, 2025, 4:00 PM
1.310
+0.020 (1.55%)
Pre-market: Apr 24, 2025, 8:01 AM EDT
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $133.46 million as of April 24, 2025. Its market cap has increased by 205.64% in one year.
Market Cap
133.46M
Enterprise Value
131.34M
1-Year Change
205.64%
Ranking
Category
Stock Price
$1.29
Market Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $133.46M, a decrease of -74.04%. That is a compound annual growth rate of -31.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 133.46M | 194.01% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 743.12B |
| UnitedHealth Group | 388.83B |
| Johnson & Johnson | 380.15B |
| AbbVie | 307.25B |
| Novo Nordisk | 266.18B |
| Abbott Laboratories | 228.46B |
| Novartis AG | 211.63B |
| AstraZeneca | 210.34B |